Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,829 DKK | +0.05% |
|
+3.63% | -15.13% |
07-17 | Genmab, J&J Log Higher Q2 Sales for Blood Cancer Drug Darzalex | MT |
07-15 | RBC Capital Upgrades Genmab to Outperform | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.13% | 16.92B | |
+20.03% | 126B | |
+23.61% | 118B | |
+23.26% | 27.87B | |
-18.07% | 20.95B | |
-14.81% | 16.18B | |
+9.78% | 14.84B | |
-46.10% | 14.79B | |
+52.34% | 14.08B | |
+143.76% | 12.57B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Transcript : Genmab A/S Presents at JP Morgan 37th Annual Healthcare conference, Jan-09-2019 03